Nektar Therapeutics News, Nektar Therapeutics Quote, NKTR Quote

Nektar Therapeutics (NQ:NKTR) Delayed: 70.70 -1.75 (2.42%)

Prev. Close

$72.45

Today 6M 1Y 5Y

Open

$71.92

52 Wk High

$19.98

52 Wk Low

$10.52

Day High

$72.98

Day Low

$70.50

P/E

N/A

EPS

$-1.45

Volume

736,629

Friends, Peers and Foes (?): LLY, ABBV, INCY, PFE, SNY (more...)

ALERTS | RSS

Mar 6, 2026 06:00 PM Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 6, 2026 10:06 AM Form SCHEDULE 13G NEKTAR THERAPEUTICS Filed by: FMR LLC
Feb 26, 2026 06:00 PM Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets
Feb 24, 2026 06:00 PM Nektar Therapeutics to Participate in Two Investor Conferences in March
Feb 23, 2026 08:15 AM Nektar Therapeutics (NKTR) PT Raised to $150 at B.Riley
Feb 20, 2026 07:10 PM Form 4 NEKTAR THERAPEUTICS For: Feb 18 Filed by: Zalevsky Jonathan
Feb 20, 2026 07:10 PM Form 4 NEKTAR THERAPEUTICS For: Feb 18 Filed by: ROBIN HOWARD W
Feb 20, 2026 02:00 PM Nektar Therapeutics (NKTR) PT Raised to $150 at B.Riley
Feb 19, 2026 05:31 PM Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
Feb 18, 2026 03:47 PM Form 144 NEKTAR THERAPEUTICS Filed by: ROBIN HOWARD W

Entities mentioned with NKTR

View All Entities